[3] viXra:2110.0153 [pdf] replaced on 2021-11-04 00:38:41
Authors: Paz Azakarian, Mino Hazit
Comments: 8 Pages.
Janssen’s SARS-CoV-2 vaccine “Ad26.CoV2.S” reported 66.9% efficacy in the trial [1]. The safety and efficacy report contains certain statistics that do not hold any value without further elaboration. The protocols set to define COVID severities do not capture enough data to validify efficacy of preventive-type medicine. Self reported side effects also suggest the safety profile needs reevaluation.
Category: Biochemistry
[2] viXra:2110.0139 [pdf] submitted on 2021-10-23 19:19:19
Authors: Paolo Pelini
Comments: 2 Pages.
The purpose of this study was to determine the different action at cellular level
in a biological model of Saccharomyces cervisiae yeast of single molecules of Hydroxyanthracene
and the same action elicited by using the entire Aloe extract
Category: Biochemistry
[1] viXra:2110.0134 [pdf] submitted on 2021-10-23 14:24:21
Authors: Paz Azakarian, Mino Hazit
Comments: 6 Pages.
SARS-CoV-2 has led to a global pandemic that resulted in a mass vaccination program in many western countries to combat the spread and severity of the illness caused by the virus. Recent studies have shown that myocarditis and pericarditis are rarely occurring side effects caused by some of the vaccines. There have been various studies that have tried to analyze how often it occured. These estimates are driven by symptomatic cases [1], though myocarditis is known to be underreported due to lack of (severe) symptoms, while it may leave long-term damage even when asymptomatic [2]. It is also one of the most common causes of sudden death in young adults. [3]
Category: Biochemistry